US EditionStronger supply chains for improved access to medicines
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The European Medicines Agency (EMA) and the network of Heads of Medicines Agencies (HMA), through the Executive Steering Group on Drug Shortage and Safety (MSSG), have recommended that EU Member States create plans to ensure the supply of anti-D immunoglobulins in the EU, guided by relevant safety, legal, ethical and regulatory aspects.
Stronger supply chains for improved access to medicines
Stronger supply chains for improved access to medicines sandrine.carpentier Fri, 07/04/2025 - 12:50 The European Commission’s proposal for a Critical Medicines Act seeks to tackle shortages by addressing supply chain vulnerabilities, such as poor diversification. The initiative also aims at strengthening the availability and accessibility of medicines for which patients encounter specific barriers (e.g., treatments for rare diseases). BEUC consi…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
